[1] Lu J,
Wang L, Li M, et al. Metabolic syndrome among adults in China: the 2010 China
noncommunicable disease surveillance[J]. J Clin Endocrinol Metab,
2017,102(2):507-515. DOI: 10.1210/jc.2016-2477.
[2] 樊佩苗,陈楠,宋琳,等.IL-6基因与TNF-α和WBC在代谢综合征中的交互作用[J].卫生研究,2021,50(2):261-266,273.DOI:10.19813/j.cnki.weishengyanjiu.2021.02.016.
[3] Babio N, Ibarrola-Jurado N, Bulló M, et
al. White blood cell counts as risk markers of developing metabolic syndrome
and its components in the PREDIMED study[J]. PLoS One, 2013,8(3):e58354. DOI:
10.1371/journal.pone.0058354.
[4] 莫沛.广州钢铁从业人群代谢综合征患病状况及与白细胞计数、红细胞分布宽度的关系[D].广州:广州医学院,2011.
[5] 宋秀霞,纪立农.国际糖尿病联盟代谢综合征全球共识定义[J].中华糖尿病杂志,2005,13(3):178-180.DOI:10.3321/j.issn:1006-6187.2005.03.010.
[6] DeFronzo RA, Ferrannini E. Insulin
resistance. A multifaceted syndrome responsible for NIDDM, obesity,
hypertension, dyslipidemia, and atherosclerotic cardiovascular disease[J].
Diabetes Care, 1991,14(3):173-194. DOI: 10.2337/diacare.14.3.173.
[7] Reaven GM. Banting lecture 1988. Role of
insulin resistance in human disease[J]. Diabetes, 1988,37(12):1595-1607. DOI:
10.2337/diab.37.12.1595.
[8] Furukawa S, Fujita T, Shimabukuro M, et
al. Increased oxidative stress in obesity and its impact on metabolic
syndrome[J]. J Clin Invest, 2004,114(12):1752-1761. DOI: 10.1172/JCI21625.
[9] Lowell BB, Shulman GI. Mitochondrial
dysfunction and type 2 diabetes[J]. Science, 2005,307(5708):384-387. DOI:
10.1126/science.1104343.
[10] Paczkowska-Abdulsalam M, Niemira M,
Bielska A, et al. Evaluation of transcriptomic regulations behind metabolic
syndrome in obese and lean subjects[J]. Int J Mol Sci, 2020,21(4):1455. DOI:
10.3390/ijms21041455.
[11] Bastard JP, Maachi M, Lagathu C, et al.
Recent advances in the relationship between obesity, inflammation, and insulin
resistance[J]. Eur Cytokine Netw, 2006,17(1):4-12.
[12] Abete I, Lu Y, Lassale C, et al. White
cell counts in relation to mortality in a general population of cohort study in
the Netherlands: a mediating effect or not?[J]. BMJ Open, 2019,9(10):e030949.
DOI: 10.1136/bmjopen-2019- 030949.
[13] Tenorio-Jiménez C, Martínez-Ramírez MJ,
Tercero-Lozano M, et al. Evaluation of the effect of Lactobacillus reuteri
V3401 on biomarkers of inflammation, cardiovascular risk and liver steatosis in
obese adults with metabolic syndrome: a randomized clinical trial (PROSIR)[J].
BMC Complement Altern Med, 2018,18(1):306. DOI: 10.1186/s12906-018-2371-x.
[14] 高璐.白细胞计数与代谢综合征及其组分间的关联性研究[D].太原:山西医科大学,2014.
[15] 任晓玲,孔渝菡,王继红,等.超敏C-反应蛋白和白细胞等指标与代谢综合征的关系[J].中国老年学杂志,2011,31(17):3221-3223.DOI:10.3969/j.issn.1005-9202.2011.17.003.
[16] 刘叶舟,杨姣梅,李敏,等.2007—2014年陕西省男性干部代谢综合征流行病学特征分析[J].实用心脑肺血管病杂志,2019,27(8):78-81. DOI:
10.3969/j.issn.1008-5971. 2019.08.016.
[17] Guevara-Cruz M, Flores-López AG,
Aguilar-López M,et al. Improvement of lipoprotein profile and metabolic
endotoxemia by a lifestyle intervention that modifies the gut microbiota in
subjects with metabolic syndrome[J]. J Am Heart Assoc, 2019,8(17):e012401. DOI:
10.1161/JAHA.119.012401.
[18] Després JP, Lemieux I. Abdominal obesity
and metabolic syndrome[J]. Nature. 2006,444(7121):881-887. DOI:
10.1038/nature05488.
|